Bio/Pharma News

Zogenix Ditches Its Controversial Drug Zohydro

March 11, 2015

Zogenix agreed to sell Zohydro, its controversial pain medication, to Pernix for $100 million.

Baxter Builds Immunology Portfolio by Acquiring Autoimmune Specialist

March 05, 2015

Baxter has bought SuppreMol, a German biopharmaceutical company that focuses on autoimmune treatments, for €200 million ($225 million USD).

AbbVie to Acquire Pharmacyclics for $21 billion

March 05, 2015

AbbVie’s acquisition of Pharmacyclics establishes the combined company as an emerging leader in hematological oncology.

Teva Announces Sale of Facility

March 03, 2015

Teva announced that it would sell its Sellersville, Pennsylvania facility to G&W Laboratories.

Hemispherx Biopharma Incorporates Continuous Manufacturing at its NJ Facility

March 03, 2015

The upgrades will offer the opportunity for higher product yields and higher purity levels.

J&J Loses First Jury Trial for Risperdal

February 25, 2015

Johnson & Johnson will pay $2.5 million to a plaintiff who developed gynecomastia after using Risperdal.

Sagent Pharmaceuticals Recalls Atracurium Besylate Injection

February 24, 2015

The company voluntarily recalls product due to FDA observations of potential sterility problems.

Aprecia Expands Capacity for 3D-Printed Dosage Manufacturing

February 24, 2015

Aprecia Pharmaceuticals' new facility in Ohio will create 150 jobs.

BMS Furthers its Immuno-Oncology Pipeline with Nearly $1.6 Billion in Investments

February 23, 2015

Bristol-Myers Squibb announced that it reached an agreement to acquire Flexus Biosciences and has entered into a $309-million partnership with Rigel Pharmaceuticals.

Kite Pharma Expands Manufacturing for T-Cell Therapies

February 23, 2015

Leased facilities in California will expand Kite Pharma's capacity for clinical T-cell therapies.